BLFS - BioLife Solutions, Inc.
| Previous Close | 16.44 |
| Open | 16.52 |
| Bid | 16.41 x 1200 |
| Ask | 16.49 x 900 |
| Day's Range | 15.95 - 16.67 |
| 52 Week Range | 9.15 - 22.44 |
| Volume | 116,618 |
| Avg. Volume | 185,227 |
| Market Cap | 329.887M |
| Beta (3Y Monthly) | 1.47 |
| PE Ratio (TTM) | 120.66 |
| EPS (TTM) | 0.14 |
| Earnings Date | Mar 8, 2019 - Mar 11, 2019 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 24.00 |
- TheStreet.com
A Quick Look at 2 Positive Looking Biotech Plays
In his "Homework" segment of Mad Money Friday night, Jim Cramer followed up on a few stocks that had stumped him during earlier shows. With its products in demand, Cramer said its valuation of 15 times earnings makes it cheap, although he cautioned that the company is small and the stock is speculative. Next, Cramer said that BioLife Solutions is another intriguing biotech play.
- PR Newswire
BioLife Solutions Awarded Three New Patents for Cryopreservation, Thawing and Cold Chain Transport Technologies
Intellectual Property Portfolio Growing with Inventions by Acquired Companies BOTHELL, Wash. , Oct. 14, 2019 /PRNewswire/ -- BioLife Solutions , Inc. (NASDAQ: BLFS), a leading developer and supplier of ...
- PR Newswire
BioLife Solutions Announces Cell and Gene Therapy Bioproduction Innovation Accelerator
BOTHELL, Wash., Sept. 24, 2019 /PRNewswire/ -- BioLife Solutions, Inc. (BLFS), a leading developer and supplier of best-in-class bioproduction tools for cell and gene therapies, today announced a co-investment accelerator program with Casdin Capital, targeting early stage companies that are developing novel cell and gene therapy bioproduction tools. Mike Rice, BioLife Solutions CEO, remarked, "It is increasingly recognized that tools and technology for bioproduction are critical for the successful development and delivery of cell and gene therapies.
- GlobeNewswire
iVexSol Announces $2M in Seed Funding
BOSTON, Sept. 24, 2019 -- iVexSol, a newly formed viral vector manufacturing company, today announced $2.0 million in new convertible debt funding led by Casdin Capital, LLC.
- PR Newswire
BioLife Solutions Announces New evo® Cold Chain Customers
BOTHELL, Wash., Sept. 16, 2019 /PRNewswire/ -- BioLife Solutions, Inc. (BLFS), a leading developer and supplier of a portfolio of best in class bioproduction tools for cell and gene therapies, today announced several new customers have adopted the evo cold chain management system in clinical trials targeting cancer and other leading causes of death. The evo system was designed by SAVSU Technologies, which was acquired by BioLife in August 2019. New evo customers joining the previously announced Mustang Bio and Novartis include Adaptimmune, Autolus, Janssen, KBI Pharma, Nanjing Legend and Tessa Therapeutics.
- GuruFocus.com
Biolife Solutions Inc (BLFS) President & CEO Michael Rice Sold $553,992 of Shares
President & CEO of Biolife Solutions Inc (30-Year Financial, Insider Trades) Michael Rice (insider trades) sold 28,571 shares of BLFS on 09/11/2019 at an average price of $19.39 a share. Continue reading...
- GuruFocus.com
Biolife Solutions Inc (BLFS) CFO Greef Roderick De Sold $593,400 of Shares
CFO of Biolife Solutions Inc (30-Year Financial, Insider Trades) Greef Roderick De (insider trades) sold 30,000 shares of BLFS on 09/06/2019 at an average price of $19.78 a share. Continue reading...
- Thomson Reuters StreetEvents
Edited Transcript of BLFS earnings conference call or presentation 8-Aug-19 8:30pm GMT
Q2 2019 Biolife Solutions Inc Earnings Call
- PR Newswire
Mustang Bio Adopts CryoStor® Freeze Media and evo® Cold Chain System for Cell and Gene Therapy Manufacturing and Distribution
Pipeline and Clinical Trials Focused on Cancers and Genetic Disorders BOTHELL, Wash. , Sept. 3, 2019 /PRNewswire/ -- BioLife Solutions , Inc. (NASDAQ: BLFS), a leading developer and supplier of a portfolio ...
- PR Newswire
BioLife Solutions Strengthens Sales Team with Key Leadership Additions
BOTHELL, Wash. , Aug. 28, 2019 /PRNewswire/ -- BioLife Solutions , Inc. (NASDAQ: BLFS), a leading developer and supplier of a portfolio of best-in-class bioproduction tools for cell and gene therapies, ...
- PR Newswire
BioLife Solutions to Attend and Present at Upcoming Scientific and Investor Conferences
BOTHELL, Wash. , Aug. 12, 2019 /PRNewswire/ -- BioLife Solutions , Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of a portfolio of best in class ...
Motley FoolBiolife Solutions Inc (BLFS) Q2 2019 Earnings Call Transcript
BLFS earnings call for the period ending June 30, 2019.
- PR Newswire
BioLife Solutions Announces Second Quarter 2019 Financial Results
- Record quarterly revenue of $6.7 million , up 29% over the prior year - Updates 2019 financial guidance to reflect Astero and SAVSU contributions - Conference Call and Webcast Begin at 4:30 pm Eastern ...
- PR Newswire
BioLife Solutions Completes Acquisition of SAVSU Technologies
BOTHELL, Wash., Aug. 8, 2019 /PRNewswire/ -- BioLife Solutions, Inc. (BLFS), a leading developer and supplier of a portfolio of best in class bioproduction tools for cell and gene therapies, today announced that it has executed a share exchange agreement to effect the acquisition of SAVSU Technologies, a leading developer of advanced cold chain management tools for cell and gene therapies. The acquisition is expected to further strengthen BioLife's position as a leading supplier of disruptive, enabling solutions used in the manufacture, storage and distribution of cell and gene therapies.
- GuruFocus.com
Biolife Solutions Inc (BLFS) CFO Greef Roderick De Sold $568,800 of Shares
CFO of Biolife Solutions Inc (30-Year Financial, Insider Trades) Greef Roderick De (insider trades) sold 30,000 shares of BLFS on 08/02/2019 at an average price of $18.96 a share. Continue reading...
- Zacks
BioLife Solutions (BLFS) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
BioLife (BLFS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- PR Newswire
BioLife Solutions to Report Second Quarter 2019 Financial Results and Provide Business Update on August 8, 2019
BOTHELL, Wash. , July 31, 2019 /PRNewswire/ -- BioLife Solutions , Inc. (NASDAQ: BLFS), the leading developer, manufacturer and marketer of proprietary clinical grade biopreservation media for cell and ...
- PR Newswire
SAVSU Technologies Expands IP Portfolio with Risk Mitigation Technologies for Shipping Cell and Gene Therapies
BOTHELL, Wash., July 30, 2019 /PRNewswire/ -- BioLife Solutions, Inc. (BLFS), a leading developer and supplier of a portfolio of best in class bioproduction tools for cell and gene therapies, today announced that SAVSU Technologies, a leading developer of advanced cold chain management tools for cell and gene therapies, and soon to be acquired by BioLife, has completed a significant expansion of its intellectual property portfolio related to protecting high value cell and gene therapies during storage and distribution.
- PR Newswire
SAVSU Technologies Partners with United Cargo® to Improve Cold Chain Management and Delivery of Cell and Gene Therapies
BOTHELL, Wash., July 23, 2019 /PRNewswire/ -- BioLife Solutions, Inc. (BLFS), a leading developer and supplier of a portfolio of best in class bioproduction tools for cell and gene therapies, today announced that SAVSU Technologies, a leading developer of advanced cold chain management tools for cell and gene therapies, has partnered with United Cargo to offer timely, efficient, same-day airport-to-airport service of vital medical shipments when time is of the utmost importance. Mike Rice, BioLife CEO, remarked, "SAVSU is continuing to build strong partnerships with best in class service providers in the cell and gene therapy distribution ecosystem.
- Insider Monkey
Hedge Funds Have Never Been This Bullish On BioLife Solutions, Inc. (BLFS)
Amid an overall bull market, many stocks that smart money investors were collectively bullish on surged during the first quarter. Among them, Facebook and Microsoft ranked among the top 3 picks and these stocks gained 40% and 25% respectively. Our research shows that most of the stocks that smart money likes historically generate strong risk-adjusted […]
- PR Newswire
BioLife Solutions to Join Russell 3000® Index
BOTHELL, Wash., June 10, 2019 /PRNewswire/ -- BioLife Solutions, Inc. (BLFS) ("BioLife" or the "Company"), the leading developer, manufacturer and marketer of proprietary biopreservation media and automated cell thawing devices for cell and gene therapies, today announced that it is set to join the broad-market Russell 3000 Index at the conclusion of the 2019 Russell indexes annual reconstitution, effective after the US market opens on July 1, according to a preliminary list of additions posted June 7. Annual Russell indexes reconstitution captures the largest US stocks as of May 10, ranking them by total market capitalization. Membership in the US all-cap Russell 3000® Index, which remains in place for one year, means automatic inclusion in the large-cap Russell 1000® Index or small-cap Russell 2000® Index as well as the appropriate growth and value style indexes.
- PR Newswire
BioLife Solutions to Present at the Jefferies 2019 Healthcare Conference
BOTHELL, Wash. , May 30, 2019 /PRNewswire/ -- BioLife Solutions , Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), the leading developer, manufacturer and marketer of proprietary ...
- PR Newswire
BioLife Solutions Announces SAVSU Technologies Selected by Novartis to Supply Advanced Cold Chain Management Platform for Newly Approved Gene Therapy
Cloud-Connected, Smart Shippers and evo.is Real-Time Visibility Platform Improve Quality of Transportation and Delivery of Lifesaving Therapies BOTHELL, Wash. , May 29, 2019 /PRNewswire/ -- BioLife Solutions, ...
- Thomson Reuters StreetEvents
Edited Transcript of BLFS earnings conference call or presentation 9-May-19 8:30pm GMT
Q1 2019 Biolife Solutions Inc Earnings Call
